Search Results - apolipoprotein-e

1 Results

Sort By:

Use of Repurposed Compounds for the Treatment of Alzheimer’s Disease

Summary: The NIA seeks co-development partners and/or licensees for the further pre-clinical and clinical development of TTI-101, hydroxychloroquine, and Dasatinib to treat Alzheimer’s disease. Description of Technology: There are no effective treatments for Alzheimer’s disease (AD), a progressive brain disease that slowly destroys a...

Published: 4/23/2026 | Updated: 8/2/2023 | Inventor(s): Madhav Thambisetty

Keywords(s): Alzheimer’s Disease, ApoE, Apolipoprotein-E, Aβ, FYN, National Institute on Aging, Neuroinflammation, NIA, STAT3, Tau Phosphorylation, Thambisetty, YES1

Category(s): Collaboration Sought > Collaboration, Application > Therapeutics, TherapeuticArea > Neurology, Collaboration Sought > Licensing